Use of npy y1 receptor antagonists in the treatment of inflammatory conditions
OwnerPatrik Ernfors, Philippe Naveilhan +2inventors
InventorsPatrik Ernfors, Philippe Naveilhan, Guilherme de Araujo Lucas, Hassameh Hassani
Life of this patent
Estimating the term…
Abstract
The present invention relates to selective neuropeptide Y (NPY) Y1 receptor antagonists. More closely, it relates to use of, and methods of using, selective NPY Y1 receptor antagonists for the treatment of inflammatory conditions. The invention also relates to use of a NPY Y1 receptor as a drug target in screening procedures to find anti-inflammatory compounds.
Claims6
Use of a selective neuropeptide Y Y1 receptor antagonist for preparation of a drug for preventing and/or treating inflammatory conditions.
Use of a NPY Y1 receptor as a drug target in screening procedures to find anti-inflammatory compounds.
Dependencies are inferred from the claim text.